dociparstat sodium (CX-01) / Cantex Pharma, Chimerix 
Welcome,         Profile    Billing    Logout  

2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dociparstat sodium (CX-01) / Cantex Pharma, Chimerix
Chimerix_COVID-19: Chimerix Announces Initiation of a Phase 2/3 Study of DSTAT in Acute Lung Injury for Patients with Severe COVID-19

Not yet recruiting
3
450
US
dociparstat sodium (CX-01) - Chimerix
Cantex, Chimerix
Severe COVID-19
 
 
NCT04571645: Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia

Terminated
3
9
US
Dociparstat, DSTAT, CX-01, 2-0,3-0 desulfated heparin, ODSH, dociparstat sodium, Control, 0.9% Normal Saline, Normal saline, Sodium chloride 0.9%
Chimerix
Acute Myeloid Leukemia
05/22
05/22

Download Options